SCHEMBL6998203

SCHEMBL6998203

O=C(NOCc1ccccc1)[C@@]1(CS(=O)(=O)c2ccc(Oc3ccc(F)cc3)cc2)C[C@H]2CC[C@@H](C1)O2

nearest known ligand 0.50

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ MMP1 P03956 10/20 0.50
▸ MMP13 P45452 10/20 0.50
▸ MMP2 P08253 7/20 0.50
▸ MMP9 P14780 5/20 0.50
▸ MMP3 P08254 4/20 0.50
▸ MMP8 P22894 3/20 0.50
▸ MMP14 P50281 3/20 0.39
▸ ABCB11 O95342 1/20 0.39
▸ MMP7 P09237 1/20 0.39
▸ MMP10 P09238 1/20 0.39
▸ ADAM17 P78536 1/20 0.39
▸ AR P10275 1/20 0.37
▸ NR3C1 P04150 1/20 0.36
▸ RORC P51449 3/20 0.36
▸ BCL2L1 Q07817 1/20 0.36
▸ MCL1 Q07820 1/20 0.36
▸ MMP12 P39900 1/20 0.36
▸ FFAR1 O14842 2/20 0.35
▸ FFAR4 Q5NUL3 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6998206 1.00 MMP1 (0.50) MMP1MMP13MMP2MMP9MMP3
SCHEMBL7000530 0.84 MMP1 (0.70) MMP1MMP13MMP2MMP9MMP3
SCHEMBL7000532 0.84 MMP1 (0.70) MMP1MMP13MMP2MMP9MMP3
SCHEMBL7000007 0.84 MMP13 (0.66) MMP1MMP13MMP2MMP9MMP3
SCHEMBL6995230 0.83 MMP1 (0.42) MMP1MMP13MMP2MMP9MMP3
SCHEMBL6995225 0.83 MMP1 (0.42) MMP1MMP13MMP2MMP9MMP3
SCHEMBL7002033 0.83 MMP1 (0.55) MMP1MMP13MMP2MMP9MMP3
SCHEMBL6995105 0.81 MMP1 (0.57) MMP1MMP13MMP2MMP9MMP3
SCHEMBL7003802 0.79 MMP1 (0.52) MMP1MMP13MMP2MMP9MMP3
SCHEMBL7003805 0.79 MMP1 (0.52) MMP1MMP13MMP2MMP9MMP3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1070069-B1 BICYCLIC HYDROXAMIC ACID DERIVATIVES PFIZER PROD INC (US) 2003-07-16 — — EP disclosed
EP-1070069-A1 BICYCLIC HYDROXAMIC ACID DERIVATIVES Pfizer Products Inc. (US) 2001-01-24 — — EP disclosed
US-6110964-A FOR TREATING ARTHRITIS, INFLAMMATORY BOWEL DISEASE, CROHN'S DISEASE, EMPHYSEMA, ACUTE RESPIRATORY DISTRESS SYNDROME, ASTHMA CHRONIC OBSTRUCTIVE PULMONARY DISEASE, ALZHEIMER'S DISEASE, ORGAN TRANSPLANT TOXICITY, CACHEXIA, CANCER PFIZER INC. (US) 2000-08-29 — — US disclosed
WO-1999052910-A1 BICYCLIC HYDROXAMIC ACID DERIVATIVES PFIZER PRODUCTS INC. (US) 1999-10-21 — — WO disclosed
Send feedback